Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-22-001594
Filing Date
2022-02-14
Accepted
2022-02-14 08:41:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 ITEOS THERAPEUTICS, INC. p22-0463sc13ga.htm SC 13G/A 61175
  Complete submission text file 0000902664-22-001594.txt   62744
Mailing Address 40 10TH AVENUE 7TH FLOOR NEW YORK NY 10014
Business Address 40 10TH AVENUE 7TH FLOOR NEW YORK NY 10014 646-597-6980
RTW INVESTMENTS, LP (Filed by) CIK: 0001493215 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 139 MAIN STREET CAMBRIDGE MA 02142
Business Address 139 MAIN STREET CAMBRIDGE MA 02142 857-204-4583
iTeos Therapeutics, Inc. (Subject) CIK: 0001808865 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91596 | Film No.: 22625693
SIC: 2836 Biological Products, (No Diagnostic Substances)